Bayer Reaffirms Commitment to China by Securing Dual Booths for the 7th CIIE

ShanghaiJanuary 10, 2024PR Newswire -- In the afternoon of January 9, Bayer, a global leader in life sciences, was invited to attend the release of "The Sixth China International Import Expo Communication Influence Report" and the signing ceremony for the Seventh Corporate Exhibition, organized by the CIIE Bureau and the National Exhibition and Convention Center (Shanghai).

This is the second early signing by Bayer for the seventh CIIE, having already secured a spot in the Medical Devices and Healthcare Products Exhibition Area in September 2023. The company has now also reserved a booth in the Food and Agricultural Products Exhibition Area. This move indicates that Bayer will participate in both exhibitions simultaneously for the third consecutive year at the seventh CIIE.

At the conference site, Bayer was also awarded three honorary titles by the CIIE Bureau: "Top 10 Exhibitors with Significant Communication Influence at the 6th China International Import Expo (CIIE)," "Top 10 Exhibitors with Communication Influence in the Medical Device and Healthcare Products Exhibition Area of the 6th CIIE Corporate Business Exhibition," and "Top 10 Exhibitors with Communication Influence in the Food and Agricultural Products Exhibition Area of the 6th CIIE Corporate Business Exhibition." This is the third consecutive year that Bayer has received these honors since 2021.

Bayer China Communications Vice President Zhang Lei stated: "For Bayer, a 'CIIE old friend' participating for the sixth consecutive year, the Chinese market is not only one of Bayer's most crucial strategic markets globally, but also one of Bayer’s most reliable and robust growth engines. The CIIE serves as an essential window for Bayer to grasp the pulse of the Chinese market and promote exchanges and cooperation with all parties. Bayer's early signing this time once again demonstrates its firm commitment and confidence in the Chinese market. In the future, we also look forward to riding the 'CIIE express' to continuously expand Bayer's influence in China, enhance the accessibility of Bayer's innovative products and solutions in China, thereby benefiting more Chinese patients, consumers, and growers, empowering the Chinese people to achieve a better life."

As a "regular participant" of the CIIE, Bayer has leveraged the CIIE platform over the past six years to accelerate the implementation of innovative achievements and deepen local exchanges and cooperation. With more, newer, and better innovative technologies and solutions in the life sciences field, Bayer has contributed to the high-quality innovative development of the industry. Just at the recently concluded sixth CIIE, Bayer, with its three divisions—Prescription Medicines (and Radiology), Consumer Health, and Crop Science—displayed over 50 innovative products and solutions, among which 15 exhibits made their debuts at the CIIE, in China, in Asia, or even globally. Meanwhile, Bayer also achieved further significant progress in local cooperation, signing more than 10 major cooperation agreements.

From the display and implementation of diversified innovative products and solutions to the achievement and advancement of multi-field local cooperation, Bayer continues to leverage the powerful spillover effects of the CIIE. Guided by the mission of "Shared Health, Eliminating Hunger," Bayer will continue to take practical actions to create a better life for patients, consumers, and farmers in China, contributing to national strategies such as Healthy China, Rural Revitalization, Common Prosperity, and High-Quality Development.

Forward-Looking Statements

This press release includes forward-looking statements by the management of Bayer AG based on current assumptions and forecasts. Various known and unknown risks, uncertainties, and other factors could cause the company's actual operational results, financial condition, development, or performance to differ materially from the estimates made in the above forward-looking statements. These factors are disclosed on Bayer's official website.www.bayer.comIn the various reports disclosed by Bayer. Bayer has no responsibility to update these forward-looking statements or to adapt them to events or developments that occur in the future.